← Eichor
Study identifier: NCT06734273 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Randomized Control Trial of Sleeve Gastrectomy With Tirzepatide in Maximizing Weight Loss

Condition: Obesity and Obesity-related Medical Conditions  ·  Sponsor: Nicholas Skertich

PhaseEARLY_Phase 1
Planned participants42
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

This study examines whether adding tirzepatide-a medication that helps with weight loss-after sleeve gastrectomy surgery can help people lose more weight after the surgery; better improve conditions like Type 2 diabetes, high blood pressure, high cholesterol, and sleep apnea after surgery and; whether this causes more complications or side effects compared to surgery alone.

This description comes directly from the study's public registry record.

Talk to the study team

Research Administrator  ·  312-942-5500  ·  anna_t_alecci@rush.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Rush University Medical CenterChicago, Illinois, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06734273